Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

35.96
+0.50501.42%
Volume:562.12K
Turnover:20.20M
Market Cap:4.24B
PE:13.00
High:36.14
Open:35.45
Low:35.21
Close:35.45
52wk High:42.81
52wk Low:22.95
Shares:118.00M
Float Shares:109.00M
Volume Ratio:0.29
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):1.64
ROE:12.20%
ROA:26.40%
PB:-20.40
PE(LYR):21.92

Loading ...

Indivior, Supernus advance merger amid disclosure updates

TIPRANKS
·
Oct 06

Indivior Pharmaceuticals Announces Special Shareholder Meeting on Merger with Supernus

Reuters
·
Oct 06

Switzerland's Addex Therapeutics Q2 Net Loss Narrows on Decline in R&D Expenses

Reuters
·
Sep 28

Addex H1 FY26 Net Loss Widens 4.29% to CHF 3.46 Million; Operating Loss Narrows 15.98% to CHF 1.13 Million

Reuters
·
Sep 28

Addex Regains Global Rights to GABAB PAM Assets from Indivior

Reuters
·
Sep 25

Indivior Announces Special Dividend Ahead of Supernus Merger

TIPRANKS
·
Sep 17

Indivior declares $8.13 per share special cash dividend

TIPRANKS
·
Sep 17

Indivior Sets USD 8.13 Special Dividend Tied to Supernus Merger Closing

Reuters
·
Sep 17

Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend

THOMSON REUTERS
·
Sep 17

Indivior Pharmaceuticals - Special Dividend Payment Contingent on Closing of Supernus Merger Expected Nov 2, 2026

THOMSON REUTERS
·
Sep 17

Indivior Terminates Supply Agreement With Reckitt Benckiser

MT Newswires Live
·
Sep 16

Indivior accelerates transition from RB manufacturing agreement

TIPRANKS
·
Sep 16

Indivior Pharmaceuticals - Copacker Supply Agreement Termination Accelerated to January 15, 2027 - SEC Filing

THOMSON REUTERS
·
Sep 16

Indivior Pharmaceuticals - Identifies New Supplier; Obligations Enforceable After Validation - SEC Filing

THOMSON REUTERS
·
Sep 16

Indivior Pharmaceuticals - Indivior UK Limited & Reckitt Benckiser Enter Deed of Variation and Termination - SEC Filing

THOMSON REUTERS
·
Sep 16

Indivior PLC Earnings Call: Merger, Margins and Growth

TIPRANKS
·
Aug 23

Amylyx Pharmaceuticals Q2 Posts Higher than Expected Loss

Reuters
·
Aug 06

Top Indivior Executive Makes Bold New Stock Move

TIPRANKS
·
Aug 06

Indivior Chief Accounting Officer Woodrow D Anderson Acquires 1,500 Shares Worth $54,420

Reuters
·
Aug 06

Vanda Pharmaceuticals Q2 Loss Widens on Lower Sales, Higher Costs

Reuters
·
Aug 06